Yes, MDMA saved this soldier from suicide

Phil Briggs
September 19, 2018 - 12:00 pm

Lubecky/Briggs Illustration


Recently, CBS News reported that MDMA (the active ingredient in the club drug Ecstasy) showed incredible results as a treatment for PTSD.

According to ongoing research being done by the Multi-Disciplinary Association for Psychedelic Studies, MDMA assisted psychotherapy sessions eliminated PTSD in 68 percent of vets treated and significantly reduced in 32 percent. 

Last Spring, we met a veteran who was part of these clinical trials, and he shared his experience on the podcast VetStory.

"If it weren't for this treatment ... I'd be dead" 

- Army combat veteran Jonathan Lubecky



In the VetStory podcast "Is Ecstasy the cure for MDMA?" we hear about; his service, his attempted suicide and how a chance encounter led him to the MDMA therapy, which he credits with saving his life.

We also hear from Brad Burge, Communications Director for the Multi-Disciplinary Association for Psychedelic Studies (MAPS) about how clinical trials with MDMA, aka "Ecstasy, Molly" are showing incredible results for veterans and those suffering from severe PTSD.

In this episode:

  • MDMA, Ecstasy, Molly ... for PTSD, really?
  • Gunner on a rooftop: Jonathan Lubecky–US Army combat veteran
  • Blown off a porta john
  • Returning Home .. to a new nightmare
  • I put the gun to my head and ...


In this episode of VetStory Lubecky, shares more vivid details about the MDMA therapy he experienced.  Also, Brad Burge, explains how MDMA works on veterans with severe PTSD and what the future holds for this drug, once thought of as merely a nightclub psychedelic. 

In this episode:

  • How does MDMA affect the brain?
  • Inside the therapy session
  • Billion dollars in savings
  • Molly, Ecstasy ... the club vs the clinic
  • Side Effects?
  • What's next?

Jonathan Lubecky's story in pictures:


Lethal Weapon: From his position above Iraqi streets,  Lubecky was lethal as an Overwatch marksman.


Killing Time: Enjoying some downtime- unaware that his days in Iraq would become his future nightmares.

Meet Molly: Doses of the pharmaceutical MDMA used in MAPS' FDA approved clinical research.

A simulation of the MDMA assisted psychotherapy sessions patients experience.


Lubecky, now an advisor with MAPS, testifying at a recent Congressional committee meeting. 

For more information about MAPS, clinical research click here 


To comment or share your story email [email protected]